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s.2011.03Abstract The whole plant of Psoralea corylifolia (PC) is traditionally used in the treatment of dia-
betes. Mice were treated with prestandardised dose of dexamethasone for 22 days and effect of PC
at the doses of 100, 200 and 300 mg/kg, p.o. on plasma blood glucose level, serum triglyceride level,
glucose uptake in skeletal muscle, levels of hepatic antioxidant enzymes (GSH, SOD, catalase and
LPO), and body weight were observed. PC showed signiﬁcant decrease in plasma glucose and serum
triglyceride levels (p< 0.01) at the dose of 100 and 200 mg/kg, p.o. and also stimulated glucose
uptake in skeletal muscle. The levels of antioxidant enzymes GSH, SOD, and catalase were signif-
icantly increased (p< 0.01) and there was signiﬁcant decrease (p< 0.01) in level of LPO.
Hence it can be concluded that Psoralea carylifolia may prove to be effective in the treatment of
Type-II Diabetes mellitus owing to its ability to decrease insulin resistance.
ª 2011 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Diabetes mellitus (DM) is the most common endocrine disor-
der. More than 150 million peoples are suffering from it world-
wide and this is likely to be increase to 300 million by the year
2025. More than one-ﬁfth of them are Indians. According to
the International Diabetes Federation, India has been declared9423467489; fax: +91 0240-
m (P.M. Tayade).
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.007as ‘‘Diabetic Capital of the World’’ at the recent conference in
Paris. Plants have been used as sources of drugs for the treat-
ment of diabetes in developing countries, where the costs of
conventional medicines are a burden to the population.
Despite the introduction of hypoglycemic agents from
natural and synthetic sources, diabetes and its secondary com-
plications continue to be a major medical problem. Many
indigenous Indian medicinal plants have found to be useful
to successfully manage diabetes. One of the greatest advanta-
ges of traditional medicinal plants is that these are readily
available and have no side effects. Even WHO has suggested
the evaluation of the potential of plants as effective therapeutic
agents, especially in areas in which we lack safe modern drugs.
Glucocorticoids in excess inhibit insulin secretion from pan-
creatic beta-cells, decrease glucose utilization and stimulate
glucagons secretion, lipolysis, proteolysis and hepatic glucoseier B.V. All rights reserved.
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both binding sites and post binding sites and cause decreased
glucose utilization in muscles. Glucocorticoids also cause insu-
lin resistance by decreasing hepatic glucose utilization and
decreasing glycogen synthesis. Free fatty acids may be elevated
in insulin resistance because of impaired insulin-dependant
down-regulation of lipolysis, hence leading to increase in tri-
glyceride levels in muscles as well as in other tissues presumably
because of excess of circulating free fatty acids, which are then
deposited in these organs. The triglycerides are reported to be
potent inhibitor of insulin signaling and result in acquired insu-
lin resistance state (Andrews and Walker, 1999).
Traditionally, Psoralea corylifolia is used in the treatment of
diabetes, lipid disorders, inﬂammation, ulcer and bronchitis
(Kirtikar and Basu, 2005). P. corylifolia is reported to have
antifungal (Xingyong et al., 2006), antidepressant (Chen et al.,
2007), antioxidant, and antibacterial activity (Naznin and
Khatunea, 2004). Taking into consideration the traditional
claims and reported activities, PC has been studied for its
anti-diabetic activity in diabetic animals. Hence the present
study was planned to investigate the effect of P. corylifolia
on dexamethasone-induced insulin resistance in mice.
2. Materials and methods
2.1. Plant material and preparation of extract
Fresh plant of P. corylifolia was collected from Aurangabad,
Maharashtra, India. The specimen was authenticated at
Dr. Babasaheb Ambedkar Marathwada University, Auranga-
bad, with voucher specimen No. 08–12 and cataloged. The
Plant was washed with distilled water and shade dried and lat-
ter powdered. This powder was then defatted with petroleum
ether and then macerated with methanol for 72 h with occa-
sional shaking. It was then ﬁltered and the solvent was evapo-
rated under vacuum. The yield of methanolic extract of
P. corylifolia (PC) was 3.4% (w/w). PC when subjected for phy-
tochemical study showed the presence of beta-sitosterol, terpe-
noids, phenolic compounds, saponins, glycosides and tannins.
2.2. Animals
Albinomice weighing 25–30 gwere used for study andwere kept
in an animal house at 26 ± 2 Cwith relative humidity 44–56%
along with light and dark cycles of 12 h. Institution Animal
Ethics Committee has approved the experimental protocol. Ani-
mals were provided with standard diet andwater ad libitum. The
food was withdrawn 18–24 h before the start of the experiment.
2.3. Experimental design
2.3.1. Acute toxicity study (OECD, 425)
The acute toxicity study for methanolic extract of P. corylifolia
was performed using albinomice. The animals were fasted over-
night prior to the experiment and maintained under standard
conditions. PC was found safe up to dose of 3000 mg/kg, orally.
2.3.2. Dexamethasone-induced insulin resistance in mice
All the mice were weighed before treatment, group I (normal
control) received equivalent amount of 1% gum acacia
(1 ml/kg, p.o.), and 30 mice were rendered hyperglycemic by
daily administration of a prestandardised dose of dexametha-sone (1 mg/kg, intramuscular) for consecutive 7 days and then
divided into ﬁve groups of six animals each. Group II (DEXA-
control) continued to receive only dexamethasone and
1%gumacacia (1 ml/kg, p.o.) for next 15 days, III received
Pioglitazone (2 mg/kg, p.o.) along with dexamethasone respec-
tively for 15 days. Groups IV–VI were treated with dexameth-
asone along with three different doses of PC100, 200, 300 mg/
kg, p.o. respectively for 15 days. Simultaneously four other
groups (groups VII–X), each with six normoglycemic animals,
were administered equivalent amount of Pioglitazone and
three different doses of PC100, 200, 300 mg/kg, p.o. respec-
tively (Table 1). On the last day, after overnight fasting, all
the animals were weighed and later sacriﬁced by cervical dislo-
cation. Blood samples were collected and used for estimation
of glucose and triglyceride (Gholap and Kar, 2005). Biochem-
ical estimation of plasma glucose and serum triglyceride was
done by GOD/POD and GPO/POD method respectively using
standard diagnostic kits from Rajesh Chemical Ltd., India.
2.3.3. Hepatic antioxidant enzymes assay (estimation of MDA,
GSH, SOD, and CAT)
Liver samples were dissected out and washed immediately with
ice cold saline to remove as much blood as possible. Liver
homogenates (5%, w/v) were prepared in cold 50 mM Tris buf-
fer (pH 7.4) using Remi homogenizer. The unbroken cells and
cell debris were removed by centrifugation at 5000 rpm for
10 min using a Remi refrigerated centrifuge. The supernatant
was used for the estimation of GSH (Ellaman, 1959), malondi-
aldehyde (MDA) (Slater and Sawyer, 1971), superoxide dismu-
tase (SOD) (Mishra and Fridovich, 1972) and catalase (Aebi
and Bergmeyer, 1974; Colowick et al., 1984) levels (Table 2).
2.3.4. Effect on glucose uptake in isolated mice hemidiaphragm
Glucose uptake in mice hemidiaphragm was estimated by the
method described by Chattopadhyay et al. (1992) with some
modiﬁcation. Twelve sets, containing graduated test tubes
(n= 6) each, were used for study of non-insulin assisted and
insulin assisted glucose uptake. The diaphragms were taken
out quickly avoiding traumas and divided into two halves.
The hemidiaphragms were rinsed in cold Tyrode solution (with-
out glucose) to remove any blood clots. In non-insulin assisted
glucose uptake study, one hemidiaphragm of each animal from
groups I to VI was exposed to 2 ml Tyrode solution with glu-
cose (2000 mg/l) in respective graduated test tubes. In insulin
assisted glucose uptake study, the remaining hemidiaphragm
of each animal from groups I to VI was exposed to 2 ml Tyrode
solution with glucose (2000 mg/l) + insulin (0.25 IU/ml) in
respective graduated test tubes. All the graduated test tubes
were incubated for 30 min at 37 C in an atmosphere of 95%
O2–5% CO2 with shaking at 140 cycles per minute. Following
incubation, the hemidiaphragm was taken out and weighed.
The glucose content of the incubated medium was measured
by GOD/POD, enzymatic method (Sabu and Subburaju,
2002; Ghosh et al., 2004).Glucose uptake was calculated as
the difference between the initial and ﬁnal glucose content in
the incubation medium (Table 3).
2.4. Statistical analysis
The results were expressed as mean ± SEM and statistically
analyzed by ANOVA followed by Dunnett test, with level of
signiﬁcance set at p< 0.05.
Table 1 Effect of Psoralea corylifolia on plasma glucose, serum triglyceride level and body weight in dexamethasone-induced insulin
resistance.
Sr. No. Groups Plasma glucose (mg/dl) Serum triglyceride (mg/dl) Body weight change (g)
I Normal control 63.37 ± 1.12 93.12 ± 1.21 +0.98 ± 0.06
II DEXA-Control 85.32 ± 0.85a** 154.36 ± 2.34a** 2.34 ± 0.16a**
III DEXA+ PIO 65.34 ± 0.87b** 95.84 ± 1.98b** +0.97 ± 0.05b**
IV DEXA+ PC 100 82.56 ± 0.68 148.49 ± 1.59 1.94 ± 0.13
V DEXA+ PC 200 76.45 ± 0.65b** 134.30 ± 2.00b** 1.83 ± 0.18
VI DEXA+ PC 300 72.27 ± 1.23b** 121.23 ± 1.78b** +0.95 ± 0.02b**
VII PIO 62.24 ± 0.54 91.97 ± 1.93 +0.99 ± 0.06
VIII PC 100 65.45 ± 0.87 96.78 ± 1.07 +0.98 ± 0.04
IX PC 200 61.26 ± 0.76 96.23 ± 0.88 +1.24 ± 0.15
X PC300 58.54 ± 0.51a* 94.54 ± 0.76 +1.15 ± 0.23
Values are expressed as mean ± SEM, n= 6, DEXA= dexamethasone 1 mg/kg, i.m., PIO= Pioglitazone 2 mg/kg, p.o., PC = Psoralea
corylifolia 100, 200, 300 mg/kg, p.o.
(+) and () sign indicates increase and decrease in body weight.
a* p< 0.05 when compared with normal control.
a** p< 0.01 when compared with normal control.
b** p< 0.01 when compared with DEXA-control.
Table 2 Effect of Psoralea corylifolia on different antioxidant enzyme levels.
Sr. no. Groups GSH (_g of GSH/g
of tissue)
SOD (units/mg
of tissue)
Catalase (_Mof H2O2/g
of tissue/min)
LPO (nM of MDA/g
of tissue)
I Normal control 26.42 ± 2.43 76.65 ± 2.95 7.83 ± 0.03 11.58 ± 0.94
II DEXA-control 13.77 ± 1.67a** 25.98 ± 1.02a** 5.07 ± 0.02a** 23.94 ± 1.27a**
III (III) DEXA+ PIO 20.58 ± 1.76b** 75.55 ± 3.62b** 5.83 ± 0.03b** 13.29 ± 0.87b**
IV DEXA+ PC-100 15.60 ± 1.35 51.81 ± 2.12b** 4.53 ± 0.02 19.63 ± 1.20b**
V DEXA+ PC-200 18.21 ± 1.57b** 60.04 ± 2.79b** 5.14 ± 0.03 14.72 ± 0.64b**
VI DEXA+ PC-300 22.31 ± 2.08b** 71.55 ± 3.98b** 6.79 ± 0.03b** 14.76 ± 0.75b**
VII PIO 25.73 ± 2.31 73.37 ± 3.21 7.81 ± 0.04 11.95 ± 1.10
VIII PC-100 23.41 ± 1.87 72.66 ± 2.87 8.06 ± 0.05 11.83 ± 0.83
IX PC-200 25.61 ± 2.10 71.80 ± 3.07 7.91 ± 0.07 11.80 ± 1.02
X PC-300 24.80 ± 2.04 72.61 ± 2.11 7.51 ± 0.05 10.90 ± 0.79
Values are expressed as mean ± SEM, n= 6, DEXA= dexamethasone 1 mg/kg, i.m., PIO= Pioglitazone 2 mg/kg, p.o., PC = Psoralea
corylifolia 100, 200, 300 mg/kg, p.o.
a** p< 0.01 when compared with normal control.
b** p< 0.01 when compared with DEXA-control.
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3.1. Effects of PC on plasma glucose, serum triglyceride and
body weight
In DEXA-control group there was signiﬁcant increase in plas-
ma glucose level (p< 0.01) and serum triglyceride level
(p< 0.01) when compared with normal control. All mice trea-
ted with DEXA and PC showed signiﬁcant decrease (p< 0.01)
in the levels of plasma glucose and serum triglyceride when
compared with DEXA-control. The mice treated with DEXA
and Pioglitazone showed signiﬁcant decrease in plasma glucose
level (p< 0.01) and serum triglyceride level (p< 0.01) when
compared with DEXA-control. PC at the dose of 300 mg/kg,
p.o. showed marginal hypoglycemia (p< 0.05) when com-
pared with normal control. Whereas signiﬁcant decrease in
the plasma glucose was observed when compared with
DEXA-control, PC at the dose of 100 & 200 mg/kg, p.o.
showed signiﬁcant reduction (p< 0.01) in plasma glucose
and triglyceride level. The percent reduction in plasma glucosewas found to be 65.45 for PC 100 mg/kg, p.o. and 61.26 for PC
200 mg/kg, p.o. Signiﬁcant reduction in body weight was ob-
served in DEXA-control group when compared with normal
control. PC and Pioglitazone treatment signiﬁcantly inhibited
the dexamethasone induced decrease in body weight
(p< 0.01) when compared DEXA-control. According to the
result it is clear that the PC has the signiﬁcant effect on DEXA
induced insulin resistance.
3.2. Effects of PC on MDA, GSH, SOD and CAT levels
In DEXA-control group there was increase in the levels
of MDA (p< 0.01) when compared with normal control,
treatment with PC signiﬁcantly prevented this rise
(p< 0.01). DEXA-control group showed signiﬁcant decrease
(p< 0.01) in GSH, SOD and CAT when compared with nor-
mal control, where as signiﬁcant increase (p< 0.01) in the lev-
els of these enzymes was observed in the PC treated groups
when compared with DEXA-control group. PC showed dose
dependent increase in the level of enzyme. PC at 100 mg/kg,
Table 3 Effect of Psoralea corylifolia on glucose uptake in mice isolated hemidiaphragm.
Sr. No. Group Non-insulin assisted glucose uptake mg/g/30 min Insulin assisted glucose uptake mg/g/30 min
I Normal 9.79 ± 0.31 15.47 ± 0.87
II DEXA-control 6.15 ± 0.35a** 9.74 ± 0.54a**
III DEXA+ PIO 8.54 ± 0.45 25.46 ± 1.34c**
IV DEXA+ PC-100 8.20 ± 0.48 16.50 ± 0.45c**
V DEXA+ PC-200 13.44 ± 0.47 19.15 ± 0.89c**
VI DEXA+ PC-300 19.56 ± 0.59b** 25.41 ± 1.12c**
Values are expressed as mean ± SEM, n= 6, DEXA= dexamethasone 1 mg/kg, i.m.
PIO = Pioglitazone 2mg/kg, p.o., PC = 100, 200, 300 mg/kg, p.o.
a** p< 0.01 when compared with normal control or normal + insulin.
b** p< 0.01 when compared with DEXA-control.
c** p< 0.01 when compared with DEXA+ insulin group.
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300 mg/kg, p.o. showed signiﬁcant increase in the enzyme
level.
3.3. Effect of PC on glucose uptake in mice isolated
hemidiaphragm
Hemidiaphragm of the mice treated with dexamethasone
showed signiﬁcant decrease (p< 0.01) in glucose uptake when
compared with normal control. Pioglitazone did not show any
signiﬁcant increase in glucose uptake by mice isolated hemidi-
aphragm. PC at higher doses i.e. 200, 300 mg/kg, p.o. showed
signiﬁcant increase (p< 0.01) in glucose uptake when com-
pared with DEXA-control. In insulin assisted glucose uptake,
Pioglitazone showed signiﬁcant increase (p< 0.01) in glucose
uptake when compared with DEXA+ insulin group. At higher
doses PC 200, 300 mg/kg, p.o. along with insulin showed sig-
niﬁcant increase (p< 0.01) in glucose uptake when compared
with DEXA+ insulin group.
4. Discussion
In the present study, the effect of PC has been studied for its
anti-diabetic activity in diabetic animals. Dexamethasone
administration at a dose of 1 mg/kg intramuscular resulted
in signiﬁcant increase in blood glucose (63.37 ± 1.12) and tri-
glyceride level (93.12 ± 1.21). Animals which show blood glu-
cose level more than 150 mg/dl were selected for the further
studies. PC showed dose dependent decrease in elevated
plasma glucose and triglyceride levels caused by dexametha-
sone. The effect of PC on the plasma glucose level and triglyc-
eride level may be due to the glucocorticoid antagonism and
the presence of other chemical constituents like terpenoids
and tannins which are reported to have antihyperglycemic ac-
tion (Matsudha et al., 2002). PC showed signiﬁcant increase in
insulin assisted glucose uptake, which indicates that there was
increase in the insulin sensitivity.
Glucocorticoid treatment is known to induce insulin resis-
tance and catabolic states in rats (Harber and Weinstein,
1992). Pharmacological doses of glucocorticoids induce ob
gene expression in rat adipocyte tissues within 24 h which is
followed by complex metabolic changes like hyperleptinemia,
resulting in decrease in food consumption, reduction in body
weight with enhanced blood glucose and triglyceride levels
(Kim et al., 2002; Shalam et al., 2006). As expected, in the pres-
ent study, dexamethasone group showed reduction in bodyweight, while PC and Pioglitazone treatment inhibited dexa-
methasone-induced reduction in body weight and showed mar-
ginal increase in body weight. The effect of PC on the body
weight may be attributed to the increase in the sensitivity to
insulin and the subsequent increase in the glucose uptake
(Schmidt et al., 1984).
Oxidative stress can be generated by hyperglycemia and for
a long time it has been accused to cause insulin resistance.
Insulin resistance induces release of cytokines like TNF-alpha,
IL-8 which leads to development of oxidative stress in liver by
reducing the mitochondrial levels of Cu/Zn SOD, glutathione
and producingH2O2 radicals and leads to increase in lipid per-
oxidation. Mitochondria are signiﬁcant source for generation
of superoxide radicals (Marfella et al., 2001). Insulin resistance
is associated with increase in fat accumulation and mitochon-
drial oxidative stress. In present study, P. corylifolia showed
signiﬁcant increase in the concentration of various antioxidant
enzymes, which could be beneﬁcial in countering, the hypergly-
cemia induced oxidative stress. Methanolic extract of PC con-
tains tannins, terpenoids and saponins (Kirtikar and Basu,
2005). Tannins and saponins play a major role in reducing oxi-
dative stress associated with diabetes (Bruneton, 1999), proba-
bly by scavenging the free radicals and preventing the
depletion of endogenous antioxidant.
Thus the results obtained in the present investigation indi-
cate that P. corylifolia may prove to be useful in insulin resis-
tance owing to its antioxidant activity and ability to increase
the glucose uptake.
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